Related by context. All words. (Click for frequent words.) 66 malignant lymphoma 65 RET PTC rearrangements 64 ADPKD 63 nasopharyngeal carcinoma 63 papillary thyroid carcinoma 63 cutaneous melanoma 62 atypical hyperplasia 62 carcinoid tumor 62 node metastases 62 astrocytomas 62 medullary thyroid cancer 62 pancreatic adenocarcinoma 62 meningiomas 62 GISTs 61 meningioma 61 distant metastases 61 prostate adenocarcinoma 61 metastatic gastric 61 neoplasm 61 soft tissue sarcomas 61 follicular thyroid cancer 61 basal cell carcinoma BCC 61 pheochromocytomas 61 papillary 61 pulmonary metastases 61 papillary carcinoma 60 advanced adenoma 60 gastric adenocarcinoma 60 gastric carcinoma 60 carcinoid tumors 60 familial pancreatic cancer 60 ductal breast cancer 60 adenomatous 60 Wilms tumor 60 esophageal squamous cell carcinoma 60 metachronous 60 renal tumors 60 squamous cell cancer 60 invasive ductal 60 paraganglioma 60 advanced adenomas 60 prostate carcinoma 60 mesotheliomas 59 acute leukemias 59 osteosarcomas 59 uveal melanoma 59 colorectal carcinoma 59 malignant neoplasm 59 PCNSL 59 gastric cancers 59 PNET 59 astrocytoma 59 bladder cancers 59 neurofibromas 59 neoplasias 59 endometrial cancers 59 pseudotumor cerebri 59 BRAF V#E 59 hepatocellular carcinoma 59 HNSCC 59 gastrointestinal stromal tumor 59 Gorlin syndrome 59 operable breast cancer 59 BRCA mutation carriers 59 metastatic bladder 59 thyroid carcinoma 59 thymoma 59 MGUS 59 thyroid nodule 59 lymphocytic 59 colorectal adenoma 59 peritoneal cancer 58 inherited mutations 58 penetrance 58 thyroid cancers 58 malignant pleural mesothelioma 58 metastatic cancer 58 neuroblastomas 58 cervical lymph nodes 58 basal cell carcinomas 58 extracapsular extension 58 hyperplastic 58 Cholangiocarcinoma 58 differentiated thyroid 58 HNPCC 58 renal cell carcinomas 58 brain metastases 58 rectal cancers 58 ependymoma 58 diffuse gastric 58 total thyroidectomy 58 CP CPPS 58 supratentorial 58 breast endometrial 58 cranial irradiation 58 contralateral breast cancer 58 carcinoid 58 pheochromocytoma 58 metastatic lung cancer 58 squamous cell cancers 58 adenomatous polyps 58 colorectal polyps 58 lymph node metastasis 58 thymic carcinoma 58 leukemia AML 58 lobular carcinoma 58 malignancy 58 bronchogenic carcinoma 58 urinary bladder cancer 58 Glioblastoma multiforme GBM 58 Hurthle cell 58 lung carcinomas 58 atypia 58 BRCA1 mutations 58 pituitary adenomas 57 colorectal neoplasms 57 locoregional recurrence 57 prostate cancer PCa 57 lymph node involvement 57 Helicobacter pylori infection 57 lobular breast cancer 57 hepatocellular carcinomas 57 nonmelanoma skin cancers 57 synovial sarcoma 57 thyroid nodules 57 biochemical recurrence 57 neoplasms 57 T1c 57 invasive ductal carcinoma 57 Leukemias 57 skeletal metastases 57 primary hyperparathyroidism 57 nodal metastases 57 MYCN amplification 57 neuroendocrine tumors 57 renal carcinoma 57 tumor recurrence 57 chlamydial infection 57 Glioblastoma Multiforme GBM 57 testicular tumors 57 primitive neuroectodermal tumors 57 idiopathic PAH 57 p# mutations 57 histologic subtype 57 proximal colon 57 paragangliomas 57 nonhereditary 57 smoldering myeloma 57 histologically confirmed 57 breast carcinoma 57 medically inoperable 57 basal cell nevus syndrome 57 Medulloblastoma 57 Acute myeloid leukemia 57 breast carcinomas 57 ovarian carcinoma 57 tumoral 57 intestinal metaplasia 57 proliferative diabetic retinopathy 57 congenital anomalies 57 Papillary 57 malignant growths 57 distant metastasis 57 pancreatic prostate 57 ovarian tumors 57 hamartomas 57 poorer prognosis 57 endometrial carcinoma 56 medulloblastoma 56 PCa 56 Anaplastic 56 locoregional 56 invasive lobular 56 pilocytic astrocytoma 56 lung adenocarcinomas 56 Severe Primary IGFD 56 papillary renal cell carcinoma 56 malignant brain 56 hepatocellular carcinoma HCC 56 leiomyosarcoma 56 Endometrial cancer 56 neuroendocrine cancers 56 adenoma 56 EGFR mutations 56 CIN3 56 sarcomatoid 56 essential thrombocythemia 56 nonmetastatic 56 Wilms tumors 56 GBA mutations 56 BRCA1 mutation carriers 56 APOL1 56 Neurofibromatosis type 56 squamous cell carcinoma SCC 56 invasive carcinoma 56 epithelial ovarian 56 heterotaxy 56 pleural mesothelioma 56 leukemia ALL 56 Basal cell 56 epithelial tumors 56 Adenomas 56 leiomyomas 56 prostate cancer CaP 56 malignant lesions 56 nodular melanoma 56 esophageal tumors 56 precancerous polyp 56 Waldenstrom macroglobulinemia 56 subependymal giant cell 56 grade glioma 56 myeloproliferative diseases 56 leukaemias 56 Wegener granulomatosis 56 colorectal adenomas 56 hereditary predisposition 56 urothelial carcinoma 56 chronic periodontitis 56 histological subtype 56 glioblastoma 56 gastric cardia 56 cerebral infarction 56 BRAF mutations 56 axillary lymph nodes 56 carcinoids 56 cisplatin resistant 56 uterine tumors 56 glioblastomas 56 colorectal liver metastases 56 peritoneal carcinomatosis 56 Metastatic 56 lobular cancer 56 acute myelogenous leukemia AML 56 Li Fraumeni syndrome 56 systemic lupus erythematosus SLE 56 malignant pancreatic 56 liposarcoma 56 dysplasias 56 carcinoma 56 mycosis fungoides 56 metastatic lymph nodes 56 anaplastic 56 chromosomal rearrangement 56 micrometastases 56 recurrent NSCLC 56 ductal adenocarcinoma 56 systemic scleroderma 56 contralateral breast 56 oesophageal adenocarcinoma 56 tumor histology 56 hepatic metastases 55 nonmelanoma skin cancer 55 hormone receptor negative 55 adrenalectomy 55 mucinous 55 serous ovarian cancer 55 colorectum 55 eosinophilic 55 schwannomas 55 tuberous sclerosis TS 55 carotid stenosis 55 CMV infection 55 grade gliomas 55 primitive neuroectodermal tumor 55 FTLD 55 malignancies 55 seminoma 55 acute lymphoblastic 55 carcinoid cancer 55 urothelial cancer 55 adenocarcinoma 55 Wilms Tumor 55 colorectal tumors 55 Hurler syndrome 55 glioma tumors 55 Adenocarcinoma 55 T1DM 55 Epstein Barr virus EBV 55 neurofibroma 55 vWD 55 fibroadenomas 55 squamous cell 55 leukemias lymphomas 55 ductal cancer 55 anal lesions 55 transitional cell carcinoma 55 atypical ductal hyperplasia 55 diabetes mellitus DM 55 Chronic myeloid leukemia CML 55 nasopharyngeal cancer 55 renal cell carcinoma 55 familial ALS 55 postoperative pathology 55 HER2 expression 55 heterotopic ossification 55 angiosarcoma 55 advanced neoplasia 55 nonmelanoma 55 intractable epilepsy 55 clinically localized prostate 55 situ DCIS 55 squamous cell carcinomas 55 lymphocytic leukemia 55 cutaneous squamous cell carcinoma 55 colorectal polyp 55 radical nephrectomy 55 postoperative delirium 55 situ LCIS 55 HER2 positive cancers 55 acute myeloid 55 esophageal adenocarcinoma 55 neoplastic 55 thyroiditis 55 neurocognitive impairment 55 colorectal adenocarcinoma 55 untreated celiac disease 55 metastases 55 Glioblastoma 55 multicentric 55 recurrent glioblastoma multiforme GBM 55 Glioma 55 familial adenomatous polyposis 55 precancerous condition 55 NKX2 55 immunocompetent 55 endometrial hyperplasia 55 embryonal rhabdomyosarcoma 55 MALT lymphoma 55 cisplatin chemotherapy 55 diffuse intrinsic pontine glioma 55 colorectal cancer CRC 55 Medullary thyroid cancer 55 lung tumors 55 gastrointestinal cancers 55 pancreatic lung 55 adenocarcinomas 55 BRCA deficient 55 acoustic neuromas 55 T1a 55 pituitary adenoma 55 unknown etiology 55 DIPG 55 BRCA mutations 55 recurrent glioblastoma multiforme 55 Gliomas 54 bone metastasis 54 axillary node 54 cancers 54 tumors 54 Chronic lymphocytic leukemia 54 paraneoplastic 54 gastric cancer 54 lung metastasis 54 hyperplastic polyps 54 cortical dysplasia 54 teratoma 54 coronary calcification 54 postoperative AF 54 HIV HCV coinfected 54 colorectal gastric 54 fibroadenoma 54 carcinomas 54 Hodgkin lymphoma HL 54 fibroma 54 BRCA2 mutations 54 pulmonary metastasis 54 cervical carcinoma 54 choriocarcinoma 54 CDH1 54 atherosclerotic lesions 54 liver metastasis 54 metaplasia 54 adrenal masses 54 sCJD 54 EoE 54 lymphoid malignancies 54 infantile hemangiomas 54 cholangiocarcinoma 54 malignant pheochromocytoma 54 metastatic malignant melanoma 54 colonic polyps 54 esophagogastric junction 54 dysplastic 54 monoclonal gammopathy 54 epididymitis 54 neoplastic lesions 54 Synovial sarcoma 54 Rhabdomyosarcoma 54 childhood leukemia 54 NMIBC 54 lymph node metastases 54 polycythemia vera 54 Glioblastoma Multiforme 54 BRAF V#E mutation 54 ovarian malignancy 54 lymph node enlargement 54 Acute Myelogenous Leukemia 54 germline mutations 54 Brain metastases 54 leukoencephalopathy 54 epithelial cancers 54 brain tumors 54 node metastasis 54 undergoing radical prostatectomy 54 testicular germ cell 54 polyp recurrence 54 neurologic complications 54 oropharyngeal cancer 54 adnexal mass 54 esophageal cancers 54 Uterine cancer 54 anterior uveitis 54 epithelial ovarian cancer 54 myeloid leukemia 54 overt hepatic encephalopathy HE 54 K ras mutations 54 metastatic disease 54 premalignant 54 VUR 54 spinocerebellar ataxia 54 KRAS wild 54 breast pancreatic 54 esophageal carcinoma 54 histological subtypes 54 lymphoblastic leukemia 54 microdeletion 54 polycythemia vera PV 54 ovarian lung 54 precursor lesions 54 orchitis 54 incidentalomas 54 malignant fibrous histiocytoma 54 ipsilateral breast 54 vestibular schwannomas 54 acute lymphoid leukemia 54 metastatic lesions 54 narcolepsy cataplexy 54 osteosarcoma 54 Candida infection 54 Hashimoto thyroiditis 54 medulloblastomas 54 TTR amyloidosis 54 polyposis 54 testicular cancers 54 varicella infection 54 resectable 54 cryptogenic stroke 54 ABCB1 54 desmoplastic 54 lymphadenopathy 54 Becker muscular dystrophy 54 metastatic adenocarcinoma 54 Sjögren syndrome 54 Basal Cell 54 CIN3 + 54 small lymphocytic lymphoma 54 intestinal polyps 54 CIN2 + 54 HER2 positive metastatic breast 54 pituitary tumors 54 microbleeds 54 hematopoietic cancers 54 neurodevelopmental impairment 54 Thyroid cancer 54 neuroblastoma tumor 54 sporadic ALS 54 MetS 54 clinicopathological 54 glioblastoma multiforme GBM 54 CaP 54 hereditary deafness 54 geographic atrophy 54 hepatorenal syndrome 54 rhabdomyosarcoma 54 clinically insignificant 54 axillary dissection 54 BRAF mutation 54 infarcts 54 CIN2 54 pancreatic carcinoma 54 lobular carcinomas 54 spontaneous regression 54 rectal carcinoma 54 PSADT 54 neuroblastoma tumors 54 colorectal neoplasia 54 EBV infection 54 HBeAg negative 54 anterior temporal 53 seminal vesicle invasion 53 ANCA associated 53 acute rheumatic fever 53 metastatic basal cell 53 unresectable tumors 53 benign polyps 53 colorectal cancer 53 recurrent VTE 53 progesterone receptor negative 53 metastatic prostate cancer 53 Uterine fibroids 53 intraepithelial neoplasia 53 neuroendocrine carcinoma 53 lung nodules 53 HGPIN 53 malignant prostate 53 Glioblastomas 53 microdeletions 53 enterocolitis 53 lobular 53 neurologic deficits 53 hamartoma 53 colon tumors 53 radiosensitive 53 ependymomas 53 chronic rhinosinusitis 53 GIST tumors 53 refractory anaplastic astrocytoma 53 Hutchinson Gilford progeria 53 cancer mCRC 53 leukemia CLL 53 rebleeding 53 nodal metastasis 53 pT3 53 preoperative chemotherapy 53 post transplant lymphoproliferative 53 gynecologic malignancy 53 invasive ductal breast cancer 53 basal cell cancers 53 hypopharynx 53 B Cell Lymphoma 53 malignant lymphomas 53 renal scarring 53 premenopausal breast cancer 53 Gastric cancer 53 metastatic neuroendocrine tumors 53 endocrine tumors 53 prostate carcinomas 53 lymphoproliferative disorders 53 immunodeficiencies 53 hypereosinophilic syndrome 53 atrophic gastritis 53 osteosarcoma rare 53 frequently benign tumor 53 estrogen receptor negative 53 Candida infections 53 squamous cell lung cancer 53 gastrointestinal stromal tumor GIST 53 GSTP1 53 gliomas 53 parkinsonism 53 adrenocortical carcinoma 53 schwannoma 53 precancerous cervical 53 hypercalcemia 53 Li Fraumeni 53 Cryptococcus neoformans 53 ccRCC 53 graft dysfunction 53 monogenic 53 HER2 overexpression 53 thyroid tumors 53 metastatic carcinoma 53 noncardiac 53 hypermethylated 53 zoster 53 ALCL 53 #q#.# [001] 53 metastatic malignant 53 hormone receptor positive 53 myeloproliferative disorder 53 thymectomy 53 juvenile idiopathic arthritis JIA 53 allogeneic bone marrow 53 juvenile idiopathic arthritis 53 metastatic RCC 53 allogeneic HSCT 53 metastatic colon cancer 53 cerebral vasospasm 53 uterine cancers 53 cell carcinomas 53 gastric carcinomas 53 lymphocytosis 53 grade cervical intraepithelial 53 Parkinsonian Syndromes 53 varicocele 53 Malignant gliomas 53 radiochemotherapy 53 EGFR mutation 53 Follicular lymphoma 53 seminomas 53 tumor subtypes 53 situ CIS 53 chlamydial infections 53 TEAEs 53 oligodendrogliomas 53 Henoch purpura 53 pre cancerous lesion 53 benign breast 53 white matter hyperintensities 53 papular 53 idiopathic scoliosis 53 colorectal carcinomas 53 androgen deprivation 53 generalized seizures 53 neurological manifestations 53 malignant neoplasms 53 herpesviruses 53 lymphangioleiomyomatosis LAM 53 Squamous 53 myoma 53 nonalcoholic steatohepatitis NASH 53 pT2 53 generalized epilepsy 53 subclinical hypothyroidism 53 Rectal cancer 53 laryngeal cancer 53 trans retinoic acid 53 basal cell cancer 53 Heavy menstrual bleeding 53 tumor necrosis 53 adenomas 53 Hepatocellular Carcinoma HCC 53 nonalcoholic steatohepatitis 53 HCV infection 53 MGd 53 mammary tumors 53 pancreatic NET 53 recurrent colorectal cancer 53 IV melanoma 53 castration resistant prostate cancer 53 pulmonary nodules 53 venous thrombosis 53 lipomas 53 myelomas 53 unexplained mental retardation 53 fallopian tube carcinoma 53 VTEs 53 malignant melanomas 53 clinicopathologic 53 aerodigestive tract 53 surgically resectable 53 Actinic Keratosis 53 melanoma lesions 53 CC genotype 53 osteoid osteoma 53 pulmonary hypertension PH 53 atherothrombotic disease 53 SLNB 53 bullous 52 radical prostatectomy RP 52 sensorineural hearing loss 52 sarcomas 52 alveolar rhabdomyosarcoma 52 rheumatic disease 52 extracranial 52 atypical hemolytic uremic syndrome 52 primary biliary cirrhosis 52 thyrotoxicosis 52 benign nodules 52 Meningiomas 52 pleural effusions 52 grade serous ovarian 52 myelogenous leukemia 52 severe neutropenia 52 Metastases 52 lymphadenectomy 52 bladder carcinoma 52 gastroesophageal junction 52 pancreatic endocrine 52 ovarian breast 52 Chronic Myelogenous Leukemia CML 52 tumors GIST 52 prostate pancreatic 52 chronic eosinophilic leukemia 52 B7 H3 52 multiforme 52 Colon polyps 52 NAFLD 52 autonomic dysfunction 52 allograft rejection 52 hypopituitarism 52 pancreatic neuroendocrine tumors 52 postmenopausal breast cancer 52 arterial calcification 52 melanoma 52 extracolonic findings 52 CMV infections 52 breast lesions 52 Chronic pancreatitis 52 recurrent glioblastoma 52 follicular lymphoma FL 52 varicoceles 52 glioblastoma tumors 52 stage IIIB 52 curable cancers 52 adjuvant radiotherapy 52 hematologic toxicity 52 Recurrences 52 subclinical hyperthyroidism 52 BRCA2 carriers 52 lymphomas 52 epilepsies 52 lung adenocarcinoma 52 malignant ovarian 52 KRAS oncogene 52 AAT deficiency 52 glioblastoma GBM 52 relapsed leukemia 52 chorioamnionitis 52 glioma 52 allogeneic stem cell 52 candidemia 52 leiomyoma 52 bronchopulmonary dysplasia 52 breast tumors 52 lymphovascular invasion 52 perioperative complications 52 squamous 52 breast cancer susceptibility genes 52 acute promyelocytic leukemia 52 cyclin E 52 interstitial pulmonary fibrosis 52 Basal cell carcinoma 52 lumbar disk herniation 52 EUS FNA 52 TT genotype 52 mammographically 52 osteochondroma 52 Chronic lymphocytic leukemia CLL 52 androgen ablation 52 BRCA2 mutation carriers 52 distal colon 52 hepatocellular carcinoma liver 52 gouty arthritis 52 cell acute lymphoblastic 52 Carcinoma 52 stage IIIb IV 52 bilateral oophorectomy 52 LQTS 52 Squamous cell carcinomas 52 cytoreduction 52 perimenopausal women 52 pre malignant lesions 52 intracerebral hemorrhage 52 GBM tumors 52 Osteosarcoma 52 AML MDS 52 lymphoma 52 JAK mutations 52 mucosal lesions 52 postoperative pulmonary 52 histologies 52 histologically 52 nonproliferative 52 autoimmune thyroiditis 52 nasopharyngeal carcinoma NPC 52 mitochondrial disorders 52 HGPS 52 neurosyphilis 52 fibrous dysplasia 52 cervical intraepithelial neoplasia 52 clinically detectable 52 cervical lesions 52 myelodysplastic syndrome MDS 52 premalignant lesions 52 Acute lymphoblastic leukemia 52 etiologies 52 lupus erythematosus 52 Nonspecific 52 ALI ARDS 52 osteochondromas 52 invasive breast cancer 52 Sezary syndrome 52 familial adenomatous polyposis FAP 52 NP CRNs 52 Barrett esophagus BE 52 chronic prostatitis 52 uterine ovarian 52 brain lesions 52 SSc 52 ductal carcinomas 52 lymphoid tumors 52 degenerative neurological diseases 52 choroidal neovascularization 52 urothelial bladder cancer 52 KIT mutations 52 metastatic 52 indolent NHL 52 Peutz Jeghers syndrome 52 mosaicism 52 stage IIIA 52 thoracic aortic aneurysm 52 interstitial lung disease 52 etiologic 52 nonsmall cell lung cancer 52 progressive neurodegenerative disorder 52 curative resection 52 minimally symptomatic 52 prognostic indicator 52 neurofibromatosis type 52 bladder tumors 52 BRAF gene 52 rectal cancer 52 presymptomatic 52 gallstone disease 52 cystic lesions 52 cranial radiation 52 necrotizing 52 pre cancerous lesions 52 bronchopulmonary dysplasia BPD 52 mammary cancers 52 myelofibrosis MF 52 spontaneously regress 52 intracranial tumors 52 ocular melanoma 52 EGFR inhibitors 52 LRP5 52 retinoblastoma 52 metastatic GIST 52 thyroid cancer 52 liver metastases 52 urolithiasis 52 pleomorphic 52 psychiatric comorbidity 52 papillomas 52 pre cancerous polyps 52 cervical neoplasia 52 aortic rupture 52 CMV disease 52 EpCAM 52 esophagitis 52 cervical uterine 52 ovarian pancreatic 52 benign tumors 52 ovarian cancers 52 dysthymic disorder 52 lung cancers 52 Myelodysplastic Syndrome 52 cancerdefine 52 de novo mutations 51 EGFR mutant 51 myeloproliferative disorders 51 BRCA1 mutation 51 Relapsing remitting MS 51 benign noncancerous 51 BRCA2 mutation 51 Burkitt lymphoma 51 androgen suppression 51 thrombophilia 51 Malignant tumors 51 malignant polyps 51 neurological abnormalities 51 lymphomas leukemias 51 Radical prostatectomy 51 Thrombocytopenia 51 endometrial cancer 51 TNF blocker therapy 51 arteriovenous malformations 51 intraductal 51 spontaneous bacterial peritonitis 51 follicular lymphoma 51 epithelioid 51 latent celiac disease 51 lymph node dissection 51 Kit CD# positive 51 hepatoblastoma 51 HER2 negative 51 Polycythemia vera 51 pancreatic tumor 51 pilocytic astrocytomas 51 proliferative retinopathy 51 unruptured aneurysm 51 EBRT 51 nonseminoma 51 lymphoid 51 genetic syndromes 51 hereditary nonpolyposis colorectal cancer 51 Alessandro Riva 51 ansamycin 51 relapsed MM 51 lacunar 51 infantile onset 51 antithyroid drugs 51 kidney urologic 51 familial hypercholesterolemia 51 acute lymphocytic leukemia 51 underwent radical prostatectomy 51 oligodendroglioma 51 chromophobe 51 lichen planus 51 ischemic colitis 51 intracranial hemorrhage ICH 51 neoplasia 51 Metastatic breast cancer 51 medium chain acyl 51 Lymphomas 51 brainstem glioma 51 KRAS mutant 51 prostate abnormalities 51 thyroglobulin 51 precancerous tumors 51 Bronchiectasis 51 heavily pretreated 51 predisposing factor 51 fibrocystic disease 51 grade dysplasia 51 keloids 51 recurrent wheezing 51 recurrent UTI 51 fungoides 51 prostate cancer CRPC 51 polyps growths 51 lymphoid cells 51 metastatic pancreatic 51 carotid plaque 51 ERBB2 51 ductal lobular 51 unresectable 51 nonmalignant 51 underactive thyroids 51 pancreatectomy 51 carcinomatosis 51 APOE ε4 51 Adjuvant chemotherapy 51 HbF 51 hyperprolactinemia 51 idiopathic myelofibrosis 51 dysgenesis 51 Acute Leukemia 51 cell carcinoma 51 MPGN 51 activating mutations 51 Thyroid nodules 51 JMML 51 PTEN mutations 51 glioma rarer 51 recurrent miscarriage 51 congenital scoliosis 51 Beta thalassemia 51 Aortic stenosis 51 sarcoma 51 Alzheimer Disease AD 51 non squamous 51 Langerhans cell histiocytosis 51 myopathies 51 lobular involution 51 rs# [002] 51 transplantation HCT 51 hematologic disorders 51 chronic HBV infection 51 acute leukemia 51 leukoplakia 51 Squamous cell 51 polycystic disease 51 thrombotic complications 51 Melanomas 51 pancreatic tumors 51 acute leukemia AML 51 metastatic tumors 51 curative therapy 51 chondrosarcoma 51 metastatic liver 51 advanced medullary thyroid 51 myeloproliferative neoplasms 51 biliary tract cancer 51 lymphoma subtypes 51 chlorambucil 51 Genetic variants 51 NF1 51 pancreatic ovarian 51 TCF#L# 51 congenital malformations 51 MSH2 51 carotid plaques 51 surgical debulking 51 Testicular cancer 51 Brugada syndrome 51 parathyroid 51 metastatic kidney 51 basal cell skin 51 HER2 positive breast cancer 51 polymyalgia 51 smoldering multiple myeloma 51 holoprosencephaly 51 hemorrhagic complications 51 parathyroid carcinoma 51 onset seizures 51 choroidal melanoma 51 taxane therapy 51 intravesical therapy 51 elevated CRP 51 pediatric malignancies 51 pCR 51 bowel polyps 51 motor neuron degeneration 51 localized renal 51 chromosomal alterations 51 lung pancreatic 51 hypoperfusion